Robbins, B. L., Capparelli, E. V., Chadwick, E. G., Yogev, R., Serchuck, L., Worrell, C., . . . Havens, P. L. (2008). Pharmacokinetics of High-Dose Lopinavir-Ritonavir with and without Saquinavir or Nonnucleoside Reverse Transcriptase Inhibitors in Human Immunodeficiency Virus-Infected Pediatric and Adolescent Patients Previously Treated with Protease Inhibitors. American Society for Microbiology (ASM).
Styl ChicagoRobbins, Brian L., et al. Pharmacokinetics of High-Dose Lopinavir-Ritonavir With and Without Saquinavir or Nonnucleoside Reverse Transcriptase Inhibitors in Human Immunodeficiency Virus-Infected Pediatric and Adolescent Patients Previously Treated With Protease Inhibitors. American Society for Microbiology (ASM), 2008.
Citace podle MLARobbins, Brian L., et al. Pharmacokinetics of High-Dose Lopinavir-Ritonavir With and Without Saquinavir or Nonnucleoside Reverse Transcriptase Inhibitors in Human Immunodeficiency Virus-Infected Pediatric and Adolescent Patients Previously Treated With Protease Inhibitors. American Society for Microbiology (ASM), 2008.